Clinical trial
A Phase 2, 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of DS-1211b in Individuals With PseudoXanthoma Elasticum
NCT05569252 is registered in ClinicalTrials.gov with Daiichi Sankyo as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2, 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of DS-1211b in Individuals With PseudoXanthoma Elasticum
- Lead sponsor
- Daiichi Sankyo
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- October 20, 2022
- Completion date
- November 21, 2023
- Enrollment
- 65 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.